ANGPT1 and neoplasm: Trebananib is a recombinant protein made by the fusion of a Fc and a peptide (peptibody) able to interact with angiopoietin 1 or 2 (Ang-1/2), impairing their binding toTIE-2 angiopoietin receptor, thus inhibiting tumor angiogenesis [111,112,113].